May 19, 2025 9:59 AM
BACK TO TOP
KSE100
119,871.70
222.56
(0.19%)
ALLSHR
74,393.21
183.96
(0.25%)
KSE30
36,661.01
59.84
(0.16%)
KMI30
181,064.97
555.92
(0.31%)
BKTI
28,776.95
-33.69
(-0.12%)
OGTI
27,842.28
133.35
(0.48%)
KMIALLSHR
51,616.32
201.15
(0.39%)
PSXDIV20
45,376.48
130.64
(0.29%)
UPP9
38,968.97
35.20
(0.09%)
NITPGI
29,988.64
46.07
(0.15%)
NBPPGI
32,670.16
119.93
(0.37%)
MZNPI
22,157.06
105.17
(0.48%)
JSMFI
33,886.38
-24.39
(-0.07%)
ACI
19,443.32
143.45
(0.74%)
JSGBKTI
33,646.19
-9.61
(-0.03%)
MII30
16,622.54
46.88
(0.28%)
HBLTTI
16,695.46
16-05-2025
14.22
(0.09%)
Ferozsons Laboratories Limited
PHARMACEUTICALS
Rs.293.00
13.72
(4.91%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, May 19, 2025 9:54 AM
REG
FUT
ODL
Open
285.50
High
295.00
Low
285.00
Volume
110,933
CIRCUIT BREAKER
251.35 — 307.21
DAY RANGE
285.00 — 295.00
52-WEEK RANGE
224.00 — 393.00
Ask Price
293.48
Ask Volume
5
Bid Price
293.00
Bid Volume
414
LDCP
279.28
VAR
14.00
HAIRCUT
17.50
P/E Ratio (TTM) **
24.50
1-Year Change *
15.96%
YTD Change *
-12.63%

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was converted into a public limited company on 08 September 1960. The Company is primarily engaged in the imports, manufacture and sale of pharmaceutical products and medical devices.

KEY PEOPLE
Osman Khalid WaheedCEO
Akhter Khalid WaheedChairperson
Syed Ghausuddin SaifCompany Secretary
ADDRESS

Ferozsons Laboratories Limited 197-A, The Mall Rawalpindi, Pakistan.

WEBSITE

www.ferozsons-labs.com

REGISTRAR

CorpTec Associates (Pvt.) Limited, 503-E, Johar Town, Lahore

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
12,736,431.94
Shares
43,469,051
Free Float
15,214,168
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2025Transmission of Quarterly Report for the Period Ended 2025-03-31 View   PDF
Apr 29, 2025Financial Results for the Quarter Ended 2025-03-31 View   PDF
Feb 28, 2025Transmission of Quarterly Report for the Period Ended 2024-12-31 View   PDF
Feb 28, 2025Financial Results for the Quarter Ended 31-12-2024 View   PDF
Oct 30, 2024Transmission of Quarterly Report for the Period Ended 2024-09-30 View   PDF
Oct 28, 2024Financial Results for the Quarter Ended 2024-09-30 View   PDF
Oct 7, 2024Transmission of Annual Report for the Year Ended 2024-06-30 View   PDF
Oct 4, 2024Financial Results for the Year Ended 2024-06-30 View   PDF
Apr 30, 2024Transmission of Quarterly Report for the Period Ended 2024-03-31 View   PDF
Apr 26, 2024Financial Results for the Quarter Ended 2024-03-31 View   PDF
DateTitleDocument
May 16, 2025Holding of Emergent Board of Directors Meeting View   
Apr 22, 2025Board Meeting View   
Feb 28, 2025Board Meeting View   
Feb 21, 2025Board Meeting View   
Oct 28, 2024Certified True Copies of the Resolutions passed in the 68th Annual General Meeting of the Company View   PDF
Oct 21, 2024Board Meeting View   
Oct 7, 2024Notice of Annual General Meeting View   PDF
Oct 7, 2024Notice of Annual General Meeting prior to publication View   PDF
Sep 27, 2024Board Meeting View   
Apr 18, 2024Board Meeting View   
Feb 21, 2024Board Meeting View   
DateTitleDocument
May 19, 2025Material Information View   PDF
Nov 26, 2024Corporate Briefing Session - Presentation View   PDF
Nov 22, 2024Corporate Briefing Session View   PDF
Nov 8, 2024Credit of Final Cash Dividend View   
Oct 18, 2024Addendum to AGM Notice View   PDF
Oct 15, 2024Postal Ballot Paper Published in Newspapers View   PDF
Oct 14, 2024Postal Ballot Paper prior to publication in Newspaper View   PDF
Oct 3, 2024Material Information View   PDF
Sep 9, 2024Material Information View   PDF
Sep 4, 2024Material Information View   
Aug 15, 2024Material Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales12,711,7149,893,3917,806,4147,033,622
Profit after Taxation400,054189,042514,149725,235
EPS9.204.3511.8320.02
Q3 2025Q2 2025Q1 2025Q3 2024
Sales3,778,6893,676,1063,356,5792,848,275
Profit after Taxation138,117111,815140,51113,319
EPS3.182.573.230.31
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)38.8838.6345.0641.04
Net Profit Margin (%)3.151.916.5910.31
EPS Growth (%)111.49(63.23)(40.91)83.33
PEG0.24(0.50)(0.56)0.21

Payouts

DateFinancial ResultsDetailsBook Closure
October 4, 2024 4:27 PM30/06/2024(YR) 30%(F) (D) 22/10/2024 - 28/10/2024
August 31, 2022 3:53 PM30/06/2022(YR) 20% (B) - 50% (D) 23/09/2022 - 30/09/2022
August 31, 2021 12:24 PM30/06/2021(YR) 100%(F) (D) 24/09/2021 - 30/09/2021
September 24, 2020 3:07 PM30/06/2020(YR) 40%(F) (D) - 20% (B) 17/10/2020 - 26/10/2020
September 23, 2019 2:47 PM30/06/2019(YR) 40%(F) (D) 18/10/2019 - 25/10/2019
February 25, 2019 12:50 PM31/12/2018(HYR) 20% (i) (D) 08/03/2019 - 14/03/2019
September 25, 2018 3:08 PM30/06/2018(YR) 20% (D) 20/10/2018 - 27/10/2018
August 30, 2017 3:38 PM30/06/2017(YR) 40% (D) M /10/2017 - 18/10/2017
January 30, 2017 3:47 PM31/12/2016(HYR) 30%(I) (D) 11/02/2017 - 19/02/2017
August 30, 2016 10:16 AM30/06/2016(YR) 120% (F) (D) 11/10/2016 - 20/10/2016

Financial Reports